CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Immunome Inc.

IMNM
$2.81BMid Cap

Next catalyst

PDUFAApr 28, 2027in 162 days

AL102

adults with desmoid tumors

Get an email about IMNM's next catalysts

Track Immunome (IMNM) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

No other upcoming event in our data.

Catalyst Timeline

1 upcoming, 2 past

PDUFANext

FDA PDUFA Date varegacestat

Apr 28, 2027AL102

For adults with desmoid tumors. NDA filing. Extracted from SEC filing: EX-99.1

Source

Upcoming FDA decisions

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaBOTHELL
Drug Pipeline

Frequently asked questions

What is in Immunome Inc.'s drug pipeline?β†’

CatalystAlert tracks 1 drug candidate in Immunome Inc.'s (IMNM) pipeline across Phase 3. Its lead program is AL102 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Immunome Inc.'s next FDA catalyst?β†’

Immunome Inc.'s (IMNM) next tracked catalyst is a PDUFA date expected Apr 28, 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track IMNM biotech catalysts?β†’

Add IMNM to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Immunome Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply